| Zhang, Lina |
OBU-BC-II-101, NCT06217185: The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). |
|
|
| Recruiting | 4 | 100 | RoW | Pyrotinib, Trastuzumab, Taxanes, Capecitabine | Hebei Medical University Fourth Hospital | HER2-positive Breast Cancer, Advanced Breast Cancer | 12/25 | 06/27 | | |
NCT06487143: Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP |
|
|
| Not yet recruiting | 4 | 134 | RoW | Triptorelin pamoate（15mg）, Triptorelin acetate （3.75mg） | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Central Precocious Puberty | 12/26 | 12/26 | | |
NCT06351150: Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock |
|
|
| Not yet recruiting | 3 | 214 | RoW | Angiotensin II Injection, 0.9% sodium chloride injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Vasodilatory Shock | 06/27 | 12/27 | | |
NCT05707832: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus |
|
|
| Not yet recruiting | 3 | 60 | RoW | Amphotericin B cholesteryl Sulfate Complex for Injection | CSPC Ouyi Pharmaceutical Co., Ltd. | Invasive Candidiasis, Invasive Aspergillosis | 08/25 | 12/25 | | |
SWATCH, NCT05265975: A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL |
|
|
| Recruiting | 1/2 | 84 | RoW | ATG-010, Selinexor, Lenalidomide, Rituximab | Antengene Corporation | Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin Lymphoma | 03/25 | 06/25 | | |
NCT05118646: Comparison of Microcirculation Indexes and Hemodynamic Indexes to Guide Resuscitation in Patients With Septic Shock |
|
|
| Recruiting | N/A | 62 | RoW | sublingual microcirculation,, hemodynamic monitoring | Xiangya Hospital of Central South University | Sepsis | 12/21 | 12/21 | | |
NCT04621981: Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis |
|
|
| Recruiting | N/A | 450 | RoW | Sodium Bicarbonate Ringer's Solution, Bicarbonated Ringer's solution, Normal Saline, physiological saline | Xiangya Hospital of Central South University | Sepsis, Septic Shock | 09/22 | 12/22 | | |
| Recruiting | N/A | 150 | RoW | Consumer wearable device | Peking University First Hospital | COPD | 09/23 | 09/23 | | |
NCT06060145: Effect of Indoor Plants on Cardiopulmonary System |
|
|
| Completed | N/A | 41 | RoW | Plants placed in an office environment, Devoid of any plant presence in an office environment | Lina Zhang, Zhejiang Chinese Medical University | Cardiopulmonary | 03/24 | 03/24 | | |
NCT04728438: Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases |
|
|
| Not yet recruiting | N/A | 100 | RoW | | Xiangya Hospital of Central South University | Ischemic Stroke, Subarachnoid Hemorrhage, Aneurysmal, Sepsis, TBI (Traumatic Brain Injury), ICH - Intracerebral Hemorrhage, HIE - Hypoxic - Ischemic Encephalopathy | 07/21 | 07/21 | | |
| Huang, Kai Ling |
SPH3127-301, NCT05359068: Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension |
|
|
| Completed | 3 | 957 | RoW | SPH3127 tablet, Valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Essential Hypertension | 12/23 | 12/23 | | |
| Terminated | 2/3 | 60 | US, RoW | NaBen®, Placebo | SyneuRx International (Taiwan) Corp | Schizophrenia | 10/23 | 10/23 | | |
NCT06322706: A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021 |
|
|
| Not yet recruiting | 1 | 36 | NA | ABSK021, Omeprazole | Abbisko Therapeutics Co, Ltd | Healthy Subjects | 12/24 | 12/25 | | |
NCT05463523: A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System |
|
|
| Recruiting | N/A | 200 | RoW | A Real-time Augmented Reality Device with Artificial Intelligence Integration | Xiangya Hospital of Central South University | Skin Diseases, Artificial Intelligence, Augmented Reality, Medical Imaging | 12/23 | 12/25 | | |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
| Deng, Shan |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
